Recently, functional in vitro studies showed that WT1 silencing through an antisense oligomer results in growth inhibition in different cancer cell lines, including breast [48]–[49], lung [50], melanoma [51]–[52], glioblastoma [53]–[54], as well as various types of solid tumors [55] cell lines. The gene discussed is WT1; the disease is glioblastoma.